PubMed:10446999
Annnotations
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 158-180 | HP_0004808 | denotes | acute myeloid leukemia |
| T2 | 164-180 | HP_0012324 | denotes | myeloid leukemia |
| T3 | 172-180 | HP_0001909 | denotes | leukemia |
| T4 | 840-862 | HP_0004808 | denotes | acute myeloid leukemia |
| T5 | 846-862 | HP_0012324 | denotes | myeloid leukemia |
| T6 | 854-862 | HP_0001909 | denotes | leukemia |
jnlpba-st-training
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 26-44 | protein | denotes | vitamin D receptor |
| T2 | 109-137 | cell_line | denotes | M2-type leukemic blast cells |
| T3 | 158-192 | cell_type | denotes | acute myeloid leukemia blast cells |
| T4 | 289-309 | cell_line | denotes | M0/M1 leukemic cells |
| T5 | 363-380 | cell_line | denotes | M3 leukemic cells |
| T6 | 483-506 | cell_line | denotes | M2 leukemic blast cells |
| T7 | 657-679 | cell_type | denotes | M2-type leukemic cells |
| T8 | 792-806 | cell_line | denotes | M2 blast cells |
| T9 | 821-835 | cell_line | denotes | Kasumi-1 cells |
| T10 | 840-880 | cell_line | denotes | acute myeloid leukemia M2-type cell line |
| T11 | 975-986 | protein | denotes | VD receptor |
| T12 | 988-991 | protein | denotes | VDR |
| T13 | 1033-1036 | protein | denotes | VDR |
| T14 | 1076-1090 | cell_line | denotes | Kasumi-1 cells |
| T15 | 1135-1154 | protein | denotes | retinoid X receptor |
| T16 | 1167-1204 | DNA | denotes | DR3-type vitamin D-responsive element |
| T17 | 1243-1295 | DNA | denotes | vitamin D-responsive element-regulated reporter gene |
| T18 | 1329-1348 | DNA | denotes | VD-responsive genes |
| T19 | 1382-1396 | cell_line | denotes | Kasumi-1 cells |
| T20 | 1571-1574 | protein | denotes | VDR |
| T21 | 1632-1648 | cell_line | denotes | M2 leukemic cell |
genia-medco-coref
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| C1 | 13-44 | NP | denotes | a functional vitamin D receptor |
| C2 | 109-137 | NP | denotes | M2-type leukemic blast cells |
| C4 | 237-267 | NP | denotes | all-trans-retinoic acid (ATRA) |
| C5 | 272-287 | NP | denotes | vitamin D3 (VD) |
| C3 | 237-287 | NP | denotes | all-trans-retinoic acid (ATRA) and vitamin D3 (VD) |
| C6 | 479-481 | NP | denotes | VD |
| C7 | 483-506 | NP | denotes | M2 leukemic blast cells |
| C8 | 534-538 | NP | denotes | they |
| C9 | 578-611 | NP | denotes | both the differentiation inducers |
| C11 | 765-769 | NP | denotes | ATRA |
| C12 | 774-776 | NP | denotes | VD |
| C10 | 765-776 | NP | denotes | ATRA and VD |
| C13 | 821-881 | NP | denotes | Kasumi-1 cells (an acute myeloid leukemia M2-type cell line) |
| C15 | 909-913 | NP | denotes | ATRA |
| C16 | 925-927 | NP | denotes | VD |
| C14 | 909-927 | NP | denotes | ATRA as well as VD |
| C17 | 975-992 | NP | denotes | VD receptor (VDR) |
| C18 | 1006-1031 | NP | denotes | monocytic differentiation |
| C19 | 1033-1036 | NP | denotes | VDR |
| C20 | 1099-1101 | NP | denotes | it |
| C21 | 1382-1396 | NP | denotes | Kasumi-1 cells |
| C22 | 1445-1470 | NP | denotes | monocytic differentiation |
| C23 | 1485-1508 | NP | denotes | The molecular mechanism |
| C24 | 1512-1517 | NP | denotes | which |
| C25 | 1518-1522 | NP | denotes | ATRA |
| C26 | 1558-1574 | NP | denotes | a functional VDR |
| C27 | 1679-1704 | NP | denotes | monocytic differentiation |
| R1 | C6 | C5 | coref-ident | VD,vitamin D3 (VD) |
| R2 | C7 | C2 | coref-ident | M2 leukemic blast cells,M2-type leukemic blast cells |
| R3 | C8 | C7 | coref-pron | they,M2 leukemic blast cells |
| R4 | C9 | C3 | coref-ident | both the differentiation inducers,all-trans-retinoic acid (ATRA) and vitamin D3 (VD) |
| R5 | C11 | C4 | coref-ident | ATRA,all-trans-retinoic acid (ATRA) |
| R6 | C12 | C6 | coref-ident | VD,VD |
| R7 | C10 | C9 | coref-ident | ATRA and VD,both the differentiation inducers |
| R8 | C15 | C11 | coref-ident | ATRA,ATRA |
| R9 | C16 | C12 | coref-ident | VD,VD |
| R10 | C14 | C10 | coref-ident | ATRA as well as VD,ATRA and VD |
| R11 | C19 | C17 | coref-ident | VDR,VD receptor (VDR) |
| R12 | C20 | C19 | coref-pron | it,VDR |
| R13 | C21 | C13 | coref-ident | Kasumi-1 cells,Kasumi-1 cells (an acute myeloid leukemia M2-type cell line) |
| R14 | C22 | C18 | coref-ident | monocytic differentiation,monocytic differentiation |
| R15 | C24 | C23 | coref-relat | which,The molecular mechanism |
| R16 | C25 | C15 | coref-ident | ATRA,ATRA |
| R17 | C26 | C1 | coref-ident | a functional VDR,a functional vitamin D receptor |
| R18 | C27 | C22 | coref-ident | monocytic differentiation,monocytic differentiation |
pubmed-sentences-benchmark
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| S1 | 0-138 | Sentence | denotes | Induction of a functional vitamin D receptor in all-trans-retinoic acid-induced monocytic differentiation of M2-type leukemic blast cells. |
| S2 | 139-288 | Sentence | denotes | Different types of acute myeloid leukemia blast cells were induced to differentiate in vitro with all-trans-retinoic acid (ATRA) and vitamin D3 (VD). |
| S3 | 289-482 | Sentence | denotes | M0/M1 leukemic cells are not sensitive to differentiating agents, whereas M3 leukemic cells are induced to undergo granulocytic differentiation after ATRA treatment but are not sensitive to VD. |
| S4 | 483-612 | Sentence | denotes | M2 leukemic blast cells behave differently because they undergo monocytic differentiation with both the differentiation inducers. |
| S5 | 613-882 | Sentence | denotes | To gain some insight into the maturation of M2-type leukemic cells, we studied the molecular mechanisms underlying monocytic differentiation induced by ATRA and VD in spontaneous M2 blast cells as well as in Kasumi-1 cells (an acute myeloid leukemia M2-type cell line). |
| S6 | 883-1032 | Sentence | denotes | Our results indicate that ATRA as well as VD efficiently increases the nuclear abundance of VD receptor (VDR) and promotes monocytic differentiation. |
| S7 | 1033-1296 | Sentence | denotes | VDR is functionally active in ATRA-treated Kasumi-1 cells because it efficiently heterodimerizes with retinoid X receptor, binds to a DR3-type vitamin D-responsive element, and activates the transcription of a vitamin D-responsive element-regulated reporter gene. |
| S8 | 1297-1484 | Sentence | denotes | Consistent with these findings, VD-responsive genes are induced by ATRA treatment of Kasumi-1 cells, suggesting that the genetic program underlying monocytic differentiation is activated. |
| S9 | 1485-1705 | Sentence | denotes | The molecular mechanism by which ATRA increases the nuclear abundance of a functional VDR is still unknown, but our data clearly indicate that the M2 leukemic cell context is only permissive of monocytic differentiation. |
GENIAcorpus
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 26-44 | protein_family_or_group | denotes | vitamin D receptor |
| T2 | 48-71 | other_organic_compound | denotes | all-trans-retinoic acid |
| T3 | 109-137 | cell_line | denotes | M2-type leukemic blast cells |
| T4 | 158-192 | cell_type | denotes | acute myeloid leukemia blast cells |
| T5 | 237-260 | other_organic_compound | denotes | all-trans-retinoic acid |
| T6 | 262-266 | other_organic_compound | denotes | ATRA |
| T7 | 272-282 | lipid | denotes | vitamin D3 |
| T8 | 284-286 | lipid | denotes | VD |
| T9 | 289-309 | cell_line | denotes | M0/M1 leukemic cells |
| T10 | 331-353 | other_organic_compound | denotes | differentiating agents |
| T11 | 363-380 | cell_line | denotes | M3 leukemic cells |
| T12 | 404-432 | other_name | denotes | granulocytic differentiation |
| T13 | 439-443 | other_organic_compound | denotes | ATRA |
| T14 | 479-481 | lipid | denotes | VD |
| T15 | 483-506 | cell_line | denotes | M2 leukemic blast cells |
| T16 | 547-572 | other_name | denotes | monocytic differentiation |
| T17 | 657-679 | cell_type | denotes | M2-type leukemic cells |
| T18 | 728-753 | other_name | denotes | monocytic differentiation |
| T19 | 765-769 | other_organic_compound | denotes | ATRA |
| T20 | 774-776 | lipid | denotes | VD |
| T21 | 792-806 | cell_line | denotes | M2 blast cells |
| T22 | 821-835 | cell_line | denotes | Kasumi-1 cells |
| T23 | 840-880 | cell_line | denotes | acute myeloid leukemia M2-type cell line |
| T24 | 909-913 | other_organic_compound | denotes | ATRA |
| T25 | 925-927 | lipid | denotes | VD |
| T26 | 975-977 | lipid | denotes | VD |
| T27 | 988-991 | protein_family_or_group | denotes | VDR |
| T28 | 1033-1036 | protein_family_or_group | denotes | VDR |
| T29 | 1063-1067 | other_organic_compound | denotes | ATRA |
| T30 | 1076-1090 | cell_line | denotes | Kasumi-1 cells |
| T31 | 1135-1154 | protein_molecule | denotes | retinoid X receptor |
| T32 | 1167-1204 | DNA_domain_or_region | denotes | DR3-type vitamin D-responsive element |
| T33 | 1243-1295 | DNA_domain_or_region | denotes | vitamin D-responsive element-regulated reporter gene |
| T34 | 1329-1331 | lipid | denotes | VD |
| T35 | 1364-1368 | other_organic_compound | denotes | ATRA |
| T36 | 1382-1396 | cell_line | denotes | Kasumi-1 cells |
| T37 | 1489-1508 | other_name | denotes | molecular mechanism |
| T38 | 1518-1522 | other_organic_compound | denotes | ATRA |
| T39 | 1571-1574 | protein_family_or_group | denotes | VDR |
| T40 | 1632-1648 | cell_line | denotes | M2 leukemic cell |
| T41 | 1679-1704 | other_name | denotes | monocytic differentiation |